No scientific evidence that it protects against depression, pain or other benefits

Eating the placenta: trendy but no proven health benefits and unknown risks

 

  • Placenta doesn’t prevent postpartum depression, ease pain, boost energy or aid lactation
  • Celebrities spike trend, but no studies show human benefits
  • Unknown risks to women and babies

 

CHICAGO, Ill., USA (June 4, 2015) – Celebrities such as Kourtney Kardashian blogged and raved about the benefits of their personal placenta ‚vitamins‘ and spiked women’s interest in the practice of consuming their placentas after childbirth. But a new Northwestern Medicine review of 10 current published research studies on placentophagy did not turn up any human or animal data to support the common claims that eating the placenta — either raw, cooked or encapsulated — offers protection against postpartum depression, reduces post-delivery pain, boosts energy, helps with lactation, promotes skin elasticity, enhances maternal bonding or replenishes iron in the body.


More concerning, there are no studies examining the risk of ingesting the placenta, called placentophagy, which acts as a filter to absorb and protect the developing fetus from toxins and pollutants, scientists said.

 

The study will be published June 4 in Archives of Women’s Mental Health.

 

‚There are a lot of subjective reports from women who perceived benefits, but there hasn’t been any systematic research investigating the benefits or the risk of placenta ingestion,‘ said corresponding study author Dr. Crystal Clark. ‚The studies on mice aren’t translatable into human benefits.‘

 

Clark is assistant professor of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine and a psychiatrist specializing in reproduction-related mood disorders at Northwestern’s Asher Center for the Study and Treatment of Depressive Disorders.

 

Placentophagy is an unknown risk for the women who eat it and for their infants, if they are breastfeeding.

 

‚Our sense is that women choosing placentophagy, who may otherwise be very careful about what they are putting into their bodies during pregnancy and nursing, are willing to ingest something without evidence of its benefits and, more importantly, of its potential risks to themselves and their nursing infants,‘ said lead author Cynthia Coyle, a Feinberg faculty member and a psychologist.

 

‚There are no regulations as to how the placenta is stored and prepared, and the dosing is inconsistent,‘ Coyle said. ‚Women really don’t know what they are ingesting.‘

 

Research is needed to provide the answers, Coyle said. She also hopes the study sparks conversations between women and their physicians about their post-birth plans, so doctors can inform their patients about the science or lack thereof and support patients in their decision-making process.

 

Clark became interested in placentophagy after some of her pregnant patients asked if eating their placentas would interfere with their antidepressant medications. She was unfamiliar with the practice and began to ask her other patients about it.

 

‚I was surprised that it was more widespread than I anticipated,‘ Clark said.

 

Although almost all non-human placental mammals ingest their placenta after giving birth, the first documented accounts of postpartum women practicing placentophagy were in North America in the 1970s, the study reports. In recent years, advocates and the media have popularized health benefits of the practice, and more women are considering it as an option for postpartum recovery.

 

‚The popularity has spiked in the last few years,‘ Clark said. ‚Our sense is that people aren’t making this decision based on science or talking with physicians. Some women are making this based on media reports, blogs and websites.‘

 

The authors of this paper are currently gathering data on the perceptions, beliefs and placental practices of health care providers internationally and nationally, as well as patients locally, and whether providers are recommending placentophagy to patients.

 

 

 

Dr. Clark’s research is supported in part by grant K12 HD055884 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health.

 

Northwestern news: http://www.northwestern.edu/newscenter/

 

 


Northwestern University, 04.06.2015 (tB).

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…